Low-risk group |
|
P value |
I2(%) |
RR |
95%CI |
P value |
30-days |
|
|
|
|
|
|
All-cause mortality |
3 |
0.92 |
I2=0 |
0.44 |
[0.20, 0.98] |
0.04 |
Cardiovascular mortality |
3 |
0.95 |
I2=0 |
0.47 |
[0.21, 1.03] |
0.06 |
Stroke |
3 |
0.11 |
I2=54 |
0.57 |
[0.22, 1.48] |
0.25 |
Transient ischemic attack |
3 |
0.25 |
I2=27 |
0.75 |
[0.17, 3.37] |
0.71 |
Myocardial infarction |
3 |
0.81 |
I2=0 |
0.65 |
[0.34, 1.22] |
0.18 |
Acute kidney injury
( stage 2 or 3)
|
3
|
0.54
|
I2=0
|
0.27
|
[0.14, 0.56]
|
0.0003
|
Life-threatening or disabling bleeding |
3 |
0.002 |
I2=83 |
0.29 |
[0.14, 0.61] |
0.001 |
Permanent pacemaker implantation |
3 |
0.002 |
I2=84 |
3.59 |
[1.43, 9.03] |
0.006 |
New-atrial fibrillation |
3 |
0.03 |
I2=72 |
0.21 |
[0.14, 0.31] |
<0.00001 |
1-year |
|
|
|
|
|
|
All-cause mortality |
3 |
0.52 |
I2=0 |
0.69 |
[0.43, 1.10] |
0.12 |
Cardiovascular mortality |
3 |
0.83 |
I2=0 |
0.56 |
[0.33, 0.94] |
0.03 |
Stroke |
3 |
0.24 |
I2=0 |
0.71 |
[0.40, 1.25] |
0.23 |
Transient ischemic attack |
3 |
0.91 |
I2=0 |
0.98 |
[0.52, 1.83] |
0.94 |
Myocardial infarction |
3 |
0.57 |
I2=0 |
0.74 |
[0.43, 1.27] |
0.28 |
Life-threatening or disabling bleeding |
2 |
0.53 |
I2=0 |
0.32 |
[0.24, 0.42] |
<0.00001 |
Permanent pacemaker implantation |
3 |
0.0002 |
I2=88 |
3.42 |
[1.33, 8.82] |
0.01 |
New-atrial fibrillation |
3 |
0.03 |
I2=69 |
0.25 |
[0.18, 0.36] |
<0.00001 |
2-years |
|
|
|
|
|
|
All-cause mortality |
2 |
0.99 |
I2=0 |
0.79 |
[0.46, 1.35] |
0.38 |
Cardiovascular mortality |
2 |
0.83 |
I2=0 |
0.66 |
[0.36, 1.20] |
0.17 |
Stroke |
2 |
0.96 |
I2=0 |
0.68 |
[0.37, 1.26] |
0.22 |
Transient ischemic attack |
2 |
0.21 |
I2=36 |
1.09 |
[0.39, 3.04] |
0.87 |
Myocardial infarction |
2 |
0.99 |
I2=0 |
0.79 |
[0.46, 1.35] |
0.38 |
Permanent pacemaker implantation |
2 |
<0.0001 |
I2=94 |
3.58 |
[0.45, 28.74] |
0.23 |
New-atrial fibrillation |
2 |
0.009 |
I2=85 |
0.27 |
[0.14, 0.51] |
<0.0001 |